PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
1-Year Return
2.57%
This Quarter Return
+0.61%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.08B
AUM Growth
-$169M
(-7.5%)
Cap. Flow
-$74.7M
Cap. Flow
% of AUM
-3.59%
Top 10 Holdings %
Top 10 Hldgs %
77.47%
Holding
49
New
4
Increased
17
Reduced
7
Closed
2
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$65.1M |
| 2 |
EPZM
Epizyme, Inc
EPZM
|
+$26.4M |
| 3 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
+$23.3M |
| 4 |
Karyopharm Therapeutics
KPTI
|
+$14.3M |
| 5 |
United Therapeutics
UTHR
|
+$11.1M |
Top Sells
| 1 |
THOR
THORATEC CORPORATION
THOR
|
+$145M |
| 2 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
+$61.7M |
| 3 |
CYBX
CYBERONICS INC
CYBX
|
+$24.5M |
| 4 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
+$12.4M |
| 5 |
ENDP
Endo International plc
ENDP
|
+$4.39M |
Sector Composition
| 1 | Healthcare | 72.2% |
